ENTPD1 and neoplasm: Collectively, the results support the hypothesis that CD39+ Tpex cells in the tumor, blood, and lymphoid tissues, characterized by high proliferative activity, are closely associated with ICB-mediated anti-tumor responses and play a critical role in therapeutic efficacy.